Consider HIV a CV "Risk Enhancer"

August 2019

Better antiretroviral therapy means more patients living with HIV will face dyslipidemia and CV disease.

HIV itself increases CV risk...possibly by triggering inflammatory mediators linked to atherosclerosis or platelet activation.

Consider nuances to managing CV risk in patients living with HIV.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote